Matt Stuttle has been in the medical industry for over 18 years. He began his career in sales and management with Forest Pharmaceuticals prior to transitioning to medical devices in 2003. Since then he’s held roles of increasing responsibility and executive management positions at Kyphon (acquired by Medtronic in 2008 for $4.3B), Paradigm Spine, Spine Wave and most recently Spineart.
Throughout his career Matt has lead sales organizations through enormous revenue growth in both private and public sectors. Prior to joining Ortho Sales Partners Matt was U.S. Vice President for Spineart, a global spine implant company based in Switzerland. During his tenure at Spineart he was instrumental in developing the US infrastructure, commercialization, distribution, product launch and market development strategies while providing necessary operational guidance. Under his leadership the organization received FDA approval for several new technologies subsequently introduced into the U.S. market while doubling U.S. sales.
Matt was also previously U.S. Vice President for Paradigm Spine where he built and scaled the initial U.S. sales and distribution infrastructure. Matt led the organization though key product launches while also assisting in management of the IDE clinical trial for Coflex, now FDA approved and market leading technology worldwide. Under his leadership the company grew from $0 to over $13M.